Literature DB >> 18541875

Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients.

D van de Beek1, R Patel, N G Campeau, A Badley, J E Parisi, A A Rabinstein, E M Manno, E F M Wijdicks.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18541875      PMCID： PMC3145203          DOI： 10.1212/01.wnl.0000314690.18731.1b

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples.

Authors:  P E Verweij; E C Dompeling; J P Donnelly; A V Schattenberg; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

2.  Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay.

Authors:  Kieren A Marr; Michel Laverdiere; Anja Gugel; Wendy Leisenring
Journal:  Clin Infect Dis       Date:  2005-05-05       Impact factor: 9.079

3.  Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.

Authors:  M Machetti; M Zotti; L Veroni; N Mordini; M T Van Lint; A Bacigalupo; D Paola; C Viscoli
Journal:  Transpl Infect Dis       Date:  2000-09       Impact factor: 2.228

4.  Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis.

Authors:  Claudio Viscoli; Marco Machetti; Paola Gazzola; Andrea De Maria; Dimitri Paola; Maria Teresa Van Lint; Francesca Gualandi; Mauro Truini; Andrea Bacigalupo
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.

Authors:  P E Verweij; K Brinkman; H P Kremer; B J Kullberg; J F Meis
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

6.  Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay.

Authors:  M Kami; S Ogawa; Y Kanda; Y Tanaka; U Machida; T Matsumura; H Sakamaki; H Hirai
Journal:  Br J Haematol       Date:  1999-08       Impact factor: 6.998

7.  CNS aspergillosis in organ transplantation: a clinicopathological study.

Authors:  J Torre-Cisneros; O L Lopez; S Kusne; A J Martinez; T E Starzl; R L Simmons; M Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154
  7 in total
  5 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis.

Authors:  Gaston Burghi; Virginie Lemiale; Amélie Seguin; Jérôme Lambert; Claire Lacroix; Emmanuel Canet; Anne-Sophie Moreau; Patricia Ribaud; David Schnell; Eric Mariotte; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2011-08-25       Impact factor: 17.440

3.  Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.

Authors:  Jonathan R Genzen; Barton Kenney
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08-29       Impact factor: 2.803

4.  Mucosal cysts of the maxillary sinus in solid organ transplant population: computerised tomography follow-up results.

Authors:  Erdinç Aydın; Hasan Yerli; Suna Tanrıkulu; Evren Hizal
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

Review 5.  Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases.

Authors:  Spinello Antinori; Mario Corbellino; Luca Meroni; Federico Resta; Salvatore Sollima; Massimo Tonolini; Anna Maria Tortorano; Laura Milazzo; Lorenzo Bello; Elisa Furfaro; Massimo Galli; Claudio Viscoli
Journal:  J Infect       Date:  2012-11-21       Impact factor: 6.072
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.